Windlas Biotech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 17/04/2026 ,inter alia, to consider and approve agenda is the proposal to buyback ....
WINDLAS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Windlas Biotech Limited has informed exchanges that its Board of Directors will meet on Friday, April 17, 2026 to consider and approve a proposal for buyback of its fully paid-up equity shares. The buyback will be conducted in accordance with the Companies Act, 2013, SEBI Buy-Back of Securities Regulations, 2018, and other applicable laws. The company also noted that the trading window for designated persons has been closed from April 1, 2026 until 48 hours after the financial results for the year ended March 31, 2026 become publicly available. No specific details about the buyback size, price, or number of shares were provided in this intimation.
A buyback approval could be positive for shareholders as it typically signals that the company believes its shares are undervalued and returns value to investors. The specific impact will depend on the buyback price and size once details are announced.